LLY

986.8

+2.02%↑

JNJ

190.4

+1.74%↑

UNH

320.08

-0.53%↓

NVS

129.85

+2.69%↑

ABT

126.37

+0.82%↑

LLY

986.8

+2.02%↑

JNJ

190.4

+1.74%↑

UNH

320.08

-0.53%↓

NVS

129.85

+2.69%↑

ABT

126.37

+0.82%↑

LLY

986.8

+2.02%↑

JNJ

190.4

+1.74%↑

UNH

320.08

-0.53%↓

NVS

129.85

+2.69%↑

ABT

126.37

+0.82%↑

LLY

986.8

+2.02%↑

JNJ

190.4

+1.74%↑

UNH

320.08

-0.53%↓

NVS

129.85

+2.69%↑

ABT

126.37

+0.82%↑

LLY

986.8

+2.02%↑

JNJ

190.4

+1.74%↑

UNH

320.08

-0.53%↓

NVS

129.85

+2.69%↑

ABT

126.37

+0.82%↑

Search

Omnicell Inc

Abierto

SectorSanidad

37.05 4.04

Resumen

Variación precio

24h

Actual

Mínimo

35.91

Máximo

37.16

Métricas clave

By Trading Economics

Ingresos

-177K

5.5M

Ventas

20M

311M

P/B

Media del Sector

77.605

77.256

BPA

0.51

Margen de beneficios

1.758

Empleados

3,670

EBITDA

-935K

29M

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 Meses

+24.02% upside

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

130M

1.5B

Apertura anterior

33.01

Cierre anterior

37.05

Noticias sobre sentimiento de mercado

By Acuity

5%

95%

4 / 374 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Strong Bearish Evidence

Omnicell Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

10 nov 2025, 22:17 UTC

Ganancias

Commonwealth Bank Posts Flat 1Q Profit Despite Margin Pressure -- Update

10 nov 2025, 21:48 UTC

Ganancias

Commonwealth Bank Posts Flat 1Q Profit Despite Margin Pressure

10 nov 2025, 23:44 UTC

Charlas de Mercado

Gold Edges Higher on Signs of Possible End to U.S. Govt Shutdown -- Market Talk

10 nov 2025, 23:43 UTC

Charlas de Mercado

Nikkei May Rise on Weaker Yen, Earnings Hopes -- Market Talk

10 nov 2025, 22:20 UTC

Adquisiciones, fusiones, absorciones

Paramount Stock Climbs as Forecast Beats Estimates -- Barrons.com

10 nov 2025, 21:50 UTC

Charlas de Mercado
Ganancias

Basic Materials Roundup: Market Talk

10 nov 2025, 21:50 UTC

Charlas de Mercado
Adquisiciones, fusiones, absorciones

Health Care Roundup: Market Talk

10 nov 2025, 21:49 UTC

Adquisiciones, fusiones, absorciones

Paramount Stock Climbs as Forecast Beats Estimates -- Barrons.com

10 nov 2025, 21:45 UTC

Ganancias

PepsiCo and 3 Other Defensive Stocks to Ride Out a Vulnerable Market -- Barrons.com

10 nov 2025, 21:40 UTC

Ganancias

Friedman Industries 2Q EPS 32c >FRD

10 nov 2025, 21:18 UTC

Ganancias

Occidental Petroleum 3Q Adj EPS 64c >OXY

10 nov 2025, 21:17 UTC

Ganancias

Occidental Petroleum 3Q EPS 65c >OXY

10 nov 2025, 21:17 UTC

Ganancias

Occidental Petroleum 3Q Rev $6.72B >OXY

10 nov 2025, 21:16 UTC

Ganancias

Occidental Petroleum 3Q EPS 65c >OXY

10 nov 2025, 21:16 UTC

Ganancias

Occidental Petroleum 3Q Adj EPS 64c >OXY

10 nov 2025, 20:30 UTC

Charlas de Mercado

Expected End to U.S. Government Shutdown Helps Lift Crude -- Market Talk

10 nov 2025, 20:24 UTC

Charlas de Mercado

Hopes For New Government Data Lift Gold -- Market Talk

10 nov 2025, 20:08 UTC

Charlas de Mercado

U.S. Natural Gas Settles Higher As Colder Weather Arrives -- Market Talk

10 nov 2025, 19:49 UTC

Charlas de Mercado

Mexican Industrial Production Seen Soft in September -- Market Talk

10 nov 2025, 19:43 UTC

Ganancias
Adquisiciones, fusiones, absorciones

Paramount Earnings Come Amid Warner Bros Merger Reports -- Barrons.com

10 nov 2025, 19:16 UTC

Ganancias

Charles Schwab's CEO Is Worried About Prediction Markets. What He Told Thousands of Financial Advisors. -- Barrons.com

10 nov 2025, 17:58 UTC

Adquisiciones, fusiones, absorciones

Eli Lilly Stock on Pace for a New High. The Zepbound Maker Just Got a Big Upgrade. -- Barrons.com

10 nov 2025, 17:56 UTC

Charlas de Mercado

Oil Futures Edge Up in Rangebound Trade -- Market Talk

10 nov 2025, 17:32 UTC

Ganancias

Barrick Looking to Reset Safety Culture Following Fatalities -- Interview

10 nov 2025, 17:30 UTC

Ganancias

Barrick Continues Efforts to Free Workers Jailed in Mali -- Interview

10 nov 2025, 17:20 UTC

Charlas de Mercado
Ganancias

Basic Materials Roundup: Market Talk

10 nov 2025, 17:20 UTC

Charlas de Mercado
Adquisiciones, fusiones, absorciones

Health Care Roundup: Market Talk

10 nov 2025, 17:00 UTC

Ganancias

Barrick Looks to Get Handle On North American Operations, Find Growth -- Interview

10 nov 2025, 17:00 UTC

Ganancias

Barrick Expects Strong Cash Flows Ahead With Commodity Prices at Current Levels, CFO Says in Interview

10 nov 2025, 17:00 UTC

Ganancias

Barrick Conducting Bottom-Up Review of Nevada Ops, Looking for Growth Opportunities

Comparación entre iguales

Cambio de precio

Omnicell Inc previsión

Precio Objetivo

By TipRanks

24.02% repunte

Estimación a 12 Meses

Media 44.25 USD  24.02%

Máximo 55 USD

Mínimo 34 USD

De acuerdo con 6 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Omnicell Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

6 ratings

4

Comprar

2

Mantener

0

Vender

Puntuación técnica

By Trading Central

24.23 / 30.44Soporte y Resistencia

Corto Plazo

Strong Bearish Evidence

Medio plazo

Strong Bearish Evidence

Largo Plazo

Bearish Evidence

Sentimiento

By Acuity

4 / 374 Clasificación en Sanidad

Noticias sobre sentimiento de mercado

Coyuntura alcista notoria

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por encima de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Omnicell Inc

Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions; IV compounding robots; and inventory management software. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.
help-icon Live chat